Biodexa Pharmaceuticals plc American Depositary Shs (BDRX)
Stock · NASDAQ · Health Care
$0.868as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$3.05
Industry
Biotechnology: Pharmaceutical Preparations
About BDRX
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. T…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 11
- Website
- www.biodexapharma.com/
Fundamentals
- 1-day range
- $0.8351$0.88
- Market cap
- $1.06M
- P/E (trailing)
- —
- P/E (forward)
- Infinity
- EPS (trailing)
- $-0.01
- Dividend yield
- —
- Beta
- 1.32
- Avg. volume
- 478.2K
- Dividend pay date
- March 3, 2020
52-week range
$0.8303$59.4
Forecasts
1 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$10.22
+1077.2%
Median
$10.22
+1077.2%
Low
$10.22
+1077.2%
Biodexa Pharmaceuticals plc American Depositary Shs Competitors
Chosen by industry and closest market cap.
- BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.8351▼ 7.21%Market cap $1.06MP/E —$0.8303$59.4
- BCTXZBriaCell Therapeutics Corp. Warrant expiring 2030$0.135▲ 12.31%Market cap $782.1KP/E —$0.0551$0.52
- CDTCDT Equity Inc. Common Stock$1.69▼ 10.37%Market cap $1.81MP/E —$1.62$2,928
- MTNBMatinas Biopharma Holdings Inc. Common Stock$0.1966▼ 1.70%Market cap $1.93MP/E —$0.178$2.14
- OGENOragenics Inc. Common Stock$0.5296▼ 0.08%Market cap $2.39MP/E —$0.4801$1.45
- SBFMSunshine Biopharma Inc. Common Stock$1.16▼ 8.66%Market cap $2.48MP/E —$1.01$24.3
- ARTLArtelo Biosciences Inc. Common Stock$0.6619▲ 0.14%Market cap $2.59MP/E —$0.52$28.14
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals plc American Depositary Shs | $1.06M | — | $0.8351 | ▼ 7.21% | $0.8303$59.4 |
| BCTXZ BriaCell Therapeutics Corp. Warrant expiring 2030 | $782.1K | — | $0.135 | ▲ 12.31% | $0.0551$0.52 |
| CDT CDT Equity Inc. Common Stock | $1.81M | — | $1.69 | ▼ 10.37% | $1.62$2,928 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.93M | — | $0.1966 | ▼ 1.70% | $0.178$2.14 |
| OGEN Oragenics Inc. Common Stock | $2.39M | — | $0.5296 | ▼ 0.08% | $0.4801$1.45 |
| SBFM Sunshine Biopharma Inc. Common Stock | $2.48M | — | $1.16 | ▼ 8.66% | $1.01$24.3 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.59M | — | $0.6619 | ▲ 0.14% | $0.52$28.14 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 8/26/2026
- Wednesday's pre-market session: top gainers and losersChartMill · 8/26/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 8/26/2026
- Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving PremarketBenzinga · 8/26/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 8/25/2026
- Stay updated with the stocks that are on the move in today's pre-market session.ChartMill · 8/25/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 8/25/2026
- Why Cadeler Are Trading Higher By 6%; Here Are 20 Stocks Moving PremarketBenzinga · 8/25/2026
- Biodexa Says 87 Of Planned 168 Subjects Recruited In Registrational Phase 3 Serenta Trial Of eRapa In Familial Adenomatous Polyposisbenzinga · 8/19/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 151
- Total value held
- $93
- Institutional holders
- 1
Top holders this quarter
- Unknown151
See the full, filterable feed with live charts on the MarketWall dashboard.